Articles

Goldman’s chief strategist is retiring after 31 years. Where he sees a bubble right now.

Goldman Sachs chief equity strategist David Kostin is retiring after 31 years — and he keeps getting peppered on his way out about whether the market’s in a bubble.

As Meghan Markle builds her food brand in her $14M California mansion, here’s what she says is her ‘great luxury’

Meghan Markle is already training her 4-year-old daughter Lilibet in the art of building a business—even as she continues to expand her own fledgling lifestyle company.

My sister, as executor, refuses to probate my father’s estate. She did the same thing when our mother died. What can I do?

“I recently received paperwork from a company that my father had invested in.”

Why Snowflake’s earnings beat isn’t enough to lift its stock

An analyst notes that growth in product revenue slowed in the latest quarter. And Snowflake shares have meaningfully outperformed peers this year, raising the bar for results.

Stock market closes on doorstep of record territory as investors focus on bright side of weak private-sector hiring

All three major U.S. stock indexes finished with back-to-back gains on Wednesday, with investors using November’s unexpectedly weak private-sector hiring report to solidify expectations for a quarter-point interest-rate cut from the Federal Reserve next week.

Salesforce cheers ‘a powerful pipeline of future revenue’ as its stock zooms higher

Salesforce said its earnings reflect AI momentum. Will the results be enough to flip bearish sentiment for an extended stretch?

Trump touts rollback of fuel standards. Here’s why it ‘won’t suddenly make cars cheaper.’

Under the Biden-era rules, carmakers would have needed to achieve a fuel-efficiency standard of about 50 miles to a gallon of gas by 2031. Trump’s proposal would lower that requirement to 34.5 miles to the gallon.

AI needs power desperately. Here’s how to invest in companies profiting from the pain.

The shortage is a lucrative opportunity — but the window is brief.

Why has Invesco’s QQQ called me two dozen times in the past few weeks? Is it a scam?

There’s a proxy vote to change the fund, and the calls will keep coming until the matter is settled.

Why ETF investors are shaking off tech-stock turbulence and AI bubble fears

ETF investors stuck with tech through a turbulent November.

Netflix and Paramount are now the favorites to buy Warner Bros., but investors don’t like it

Share prices for both suitors are down over 5% as details emerge of cash bids for the owner of HBO and CNN.

A delayed clinical trial actually boosted Bristol Myers Squibb’s stock. Here’s why.  

Bristol Myers’ stock rallied Wednesday as investors maintained high hopes for Cobenfy as an Alzheimer’s treatment, even though the outcome of a late-stage trial has been delayed.
1 51 52 53 54 55 2,516